Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Lancet Neurol. 2015 Jun 29;14(8):804–813. doi: 10.1016/S1474-4422(15)00135-0

Figure 1. Raw data and estimated group trajectories of neuroimaging and clinical markers.

Figure 1

Raw data for each neuroimaging and clinical marker is plotted against EYO (top row). Each contiguous colored line represents longitudinal data from a single participant. Raw data is being presented without smoothing or jitter as all participants are aware of their mutation status. The estimated trajectory and 99% CI from the mixed models (blue line + blue shaded area) are plotted against EYO for each marker (bottom row). For the hippocampal W-score trajectories, open diamond markers were used to indicate measurements acquired on the 1·5T scanner. A regression correction function had been applied to these measurements to correct for scanner differences.